ORKA · Oruka Therapeutics, Inc.
$94.32
+2.61 (+2.85%)
At close · Jul 21
Market Cap
$5.69B
Shares
60.31M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Lawrence Klein | CEO | $3,356,050 |
| Paul Quinlan | General Counsel and Corporate Secretary | $2,338,593 |
| Joana Goncalves | Chief Medical Officer | $2,338,593 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Thomas A. Keuer | COO | $853,520 |
| C. Jeffrey Dekker | CFO | $756,604 |
| Lawrence Klein | CEO | $520,911 |
| Michael Bristow | CEO | $510,416 |
| Joana Goncalves | Chief Medical Officer | $317,986 |
| General Counsel | — | $317,986 |
| Paul Quinlan | General Counsel and Corporate Secretary | $310,445 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Thomas A. Keuer | COO | $400,802 |
| Michael Bristow | CEO | $358,800 |
| C. Jeffrey Dekker | CFO | $323,072 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Thomas A. Keuer | COO | $448,993 |
| Michael Bristow | CEO | $358,800 |
| Christopher D. Ozeroff | Secretary, Senior Vice President and General Counsel | $316,429 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Michael Bristow | CEO | $526,513 |
| Thomas A. Keuer | COO | $420,615 |
| Christopher D. Ozeroff | General Counsel | $366,029 |
| Former Secretary | General Counsel | $366,029 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Michael Bristow | CEO | $1,061,587 |
| Thomas A. Keuer | COO | $631,024 |
| Christopher D. Ozeroff | General Counsel | $555,848 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Thomas A. Keuer | COO | $304,022 |
| Michael Bristow | CEO | $296,151 |
| Christopher D. Ozeroff | General Counsel | $290,157 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Thomas A. Keuer | COO | $326,786 |
| Michael Bristow | CEO | $320,490 |
| Christopher D. Ozeroff | General Counsel | $310,257 |
Key facts
CIK
907654
CUSIP
687604108
13F (30d)
16 filings
16 filers
Visit website
Investor relations